Cargando…

MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence

Cellular junctions play a critical role in structural connection and signal communication between cells in various tissues. Although there are structural and functional varieties, cellular junctions include tight junctions, adherens junctions, focal adhesion junctions, and tissue specific junctions...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Yugang, Peng, Hu, Mastej, Victoria, Chen, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143735/
https://www.ncbi.nlm.nih.gov/pubmed/27999452
http://dx.doi.org/10.1155/2016/5078627
_version_ 1782472988736618496
author Zhuang, Yugang
Peng, Hu
Mastej, Victoria
Chen, Weiguo
author_facet Zhuang, Yugang
Peng, Hu
Mastej, Victoria
Chen, Weiguo
author_sort Zhuang, Yugang
collection PubMed
description Cellular junctions play a critical role in structural connection and signal communication between cells in various tissues. Although there are structural and functional varieties, cellular junctions include tight junctions, adherens junctions, focal adhesion junctions, and tissue specific junctions such as PECAM-1 junctions in endothelial cells (EC), desmosomes in epithelial cells, and hemidesmosomes in EC. Cellular junction dysfunction and deterioration are indicative of clinical diseases. MicroRNAs (miRNA) are ~20 nucleotide, noncoding RNAs that play an important role in posttranscriptional regulation for almost all genes. Unsurprisingly, miRNAs regulate junction protein gene expression and control junction structure integrity. In contrast, abnormal miRNA regulation of junction protein gene expression results in abnormal junction structure, causing related diseases. The major components of tight junctions include zonula occluden-1 (ZO-1), claudin-1, claudin-5, and occludin. The miRNA regulation of ZO-1 has been intensively investigated. ZO-1 and other tight junction proteins such as claudin-5 and occludin were positively regulated by miR-126, miR-107, and miR21 in different models. In contrast, ZO-1, claudin-5, and occludin were negatively regulated by miR-181a, miR-98, and miR150. Abnormal tight junction miRNA regulation accompanies cerebral middle artery ischemia, brain trauma, glioma metastasis, and so forth. The major components of adherens junctions include VE-cadherin, β-catenin, plakoglobin, P120, and vinculin. VE-cadherin and β-catenin were regulated by miR-9, miR-99b, miR-181a, and so forth. These regulations directly affect VE-cadherin-β-catenin complex stability and further affect embryo and tumor angiogenesis, vascular development, and so forth. miR-155 and miR-126 have been shown to regulate PECAM-1 and affect neutrophil rolling and EC junction integrity. In focal adhesion junctions, the major components are integrin β4, paxillin, and focal adhesion kinase (FAK). Integrin β4 has been regulated by miR-184, miR-205, and miR-9. Paxillin has been regulated by miR-137, miR-145, and miR-218 in different models. FAK has been regulated by miR-7, miR-138, and miR-135. Deregulation of miRNAs is caused by viral infections, tumorigenesis, and so forth. By regulation of posttranscription, miRNAs manipulate junction protein expression in all cellular processes and further determine cellular fate and development. Elucidation of these regulatory mechanisms will become a new alternative therapy for many diseases, such as cancers and inflammatory diseases.
format Online
Article
Text
id pubmed-5143735
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51437352016-12-20 MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence Zhuang, Yugang Peng, Hu Mastej, Victoria Chen, Weiguo Mediators Inflamm Review Article Cellular junctions play a critical role in structural connection and signal communication between cells in various tissues. Although there are structural and functional varieties, cellular junctions include tight junctions, adherens junctions, focal adhesion junctions, and tissue specific junctions such as PECAM-1 junctions in endothelial cells (EC), desmosomes in epithelial cells, and hemidesmosomes in EC. Cellular junction dysfunction and deterioration are indicative of clinical diseases. MicroRNAs (miRNA) are ~20 nucleotide, noncoding RNAs that play an important role in posttranscriptional regulation for almost all genes. Unsurprisingly, miRNAs regulate junction protein gene expression and control junction structure integrity. In contrast, abnormal miRNA regulation of junction protein gene expression results in abnormal junction structure, causing related diseases. The major components of tight junctions include zonula occluden-1 (ZO-1), claudin-1, claudin-5, and occludin. The miRNA regulation of ZO-1 has been intensively investigated. ZO-1 and other tight junction proteins such as claudin-5 and occludin were positively regulated by miR-126, miR-107, and miR21 in different models. In contrast, ZO-1, claudin-5, and occludin were negatively regulated by miR-181a, miR-98, and miR150. Abnormal tight junction miRNA regulation accompanies cerebral middle artery ischemia, brain trauma, glioma metastasis, and so forth. The major components of adherens junctions include VE-cadherin, β-catenin, plakoglobin, P120, and vinculin. VE-cadherin and β-catenin were regulated by miR-9, miR-99b, miR-181a, and so forth. These regulations directly affect VE-cadherin-β-catenin complex stability and further affect embryo and tumor angiogenesis, vascular development, and so forth. miR-155 and miR-126 have been shown to regulate PECAM-1 and affect neutrophil rolling and EC junction integrity. In focal adhesion junctions, the major components are integrin β4, paxillin, and focal adhesion kinase (FAK). Integrin β4 has been regulated by miR-184, miR-205, and miR-9. Paxillin has been regulated by miR-137, miR-145, and miR-218 in different models. FAK has been regulated by miR-7, miR-138, and miR-135. Deregulation of miRNAs is caused by viral infections, tumorigenesis, and so forth. By regulation of posttranscription, miRNAs manipulate junction protein expression in all cellular processes and further determine cellular fate and development. Elucidation of these regulatory mechanisms will become a new alternative therapy for many diseases, such as cancers and inflammatory diseases. Hindawi Publishing Corporation 2016 2016-11-24 /pmc/articles/PMC5143735/ /pubmed/27999452 http://dx.doi.org/10.1155/2016/5078627 Text en Copyright © 2016 Yugang Zhuang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zhuang, Yugang
Peng, Hu
Mastej, Victoria
Chen, Weiguo
MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title_full MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title_fullStr MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title_full_unstemmed MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title_short MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence
title_sort microrna regulation of endothelial junction proteins and clinical consequence
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143735/
https://www.ncbi.nlm.nih.gov/pubmed/27999452
http://dx.doi.org/10.1155/2016/5078627
work_keys_str_mv AT zhuangyugang micrornaregulationofendothelialjunctionproteinsandclinicalconsequence
AT penghu micrornaregulationofendothelialjunctionproteinsandclinicalconsequence
AT mastejvictoria micrornaregulationofendothelialjunctionproteinsandclinicalconsequence
AT chenweiguo micrornaregulationofendothelialjunctionproteinsandclinicalconsequence